| Mechanisms Underlying the Waning of Osteoanabolic Therapy Effects in Osteoporosis | Journal of bone and mineral research | | | 2026 | 9 | 109 |
|
| Predictive value of BMD for hip and other fractures : a meta-analysis to update FRAX | Osteoporosis international | | | 2026 | 12 | 0 |
|
| A simple personalised prediction model for hip fracture risk based on mechanistic parameters | Biomechanics and modeling in mechanobiology | | | 2026 | 5 | 0 |
|
| A meta-analysis of smoking and fracture risk to update the FRAX® tool | Osteoporosis international | | | 2026 | 7 | 0 |
|
| The gut-bone axis : microbial metabolism and nutritional interventions for bone health | Gut microbes | | | 2026 | 1 | 0 |
|
| Orthogeriatric Fracture Syndrome : A Large-Scale Bibliometric Analysis of a Proposed Concept for Cross-Disciplinary Awareness and Coordinated Care | Journal of clinical medicine | | | 2026 | 1 | 1 |
|
| Insulin therapy improves bone microstructure and material properties without restoring whole-bone strength in male insulin-deficient Akita mice | Bone | | | 2026 | 4 | 0 |
|
| Phase 3 study comparing the efficacy and safety of proposed biosimilar RGB-14-P with denosumab in postmenopausal women with osteoporosis : results from the transition (switch) phase | Osteoporosis international | | | 2026 | 1 | 0 |
|
| Early transition from short-term romosozumab to antiresorptive therapies : analysis of 26 cases | Archives of osteoporosis | | | 2025 | 11 | 100 |
|
| Traitements médicamenteux séquentiels de l’ostéoporose | Revue médicale suisse | | | 2025 | 47 | 1 |
|
| Real-world data from a national survey on management of CKD-associated osteoporosis among Italian nephrologists | Archives of osteoporosis | | | 2025 | 26 | 1 |
|
| Rheumatoid arthritis and subsequent fracture risk : an individual person meta-analysis to update FRAX | Osteoporosis international | | | 2025 | 63 | 0 |
|
| LUMIADE 3 : Therapeutic Equivalence of Denosumab Biosimilar FKS518 to Reference Product in Postmenopausal Osteoporosis | Journal of the Endocrine Society | | | 2025 | 9 | 60 |
|
| Effects of romosozumab and teriparatide on hip bone using 3D-SHAPER in postmenopausal women with osteoporosis | JBMR plus | | | 2025 | 14 | 197 |
|
| Romosozumab following denosumab improves lumbar spine bone mineral density and trabecular bone score more than denosumab continuation in postmenopausal women | Journal of bone and mineral research | | | 2025 | 10 | 0 |
|
| A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis | Osteoporosis international | | | 2025 | 15 | 18 |
|
| Body mass index and subsequent fracture risk : a meta-analysis to update FRAX | Journal of bone and mineral research | | | 2025 | 15 | 189 |
|
| Are low-trauma fractures all fragility fractures ? Insights into musculoskeletal and body composition characteristics of community-dwelling post-menopausal women with a recent fracture | Aging Clinical and Experimental Research | | | 2025 | 32 | 105 |
|
| A Consensus Statement on the management of Vertebral Fractures in CKD stages G4-G5D | Nephrology, dialysis, transplantation | | | 2025 | 18 | 249 |
|
| Romosozumab Improves Tissue Thickness-Adjusted Trabecular Bone Score in Women With Osteoporosis and Diabetes | The Journal of clinical endocrinology and metabolism | | | 2025 | 77 | 378 |
|
| Asia-Pacific consensus for the management of osteoporosis in men | Osteoporosis international | | | 2025 | 49 | 246 |
|
| Bone microstructure and TBS in diabetes: what have we learned ? A narrative review | Osteoporosis international | | | 2025 | 11 | 0 |
|
| Family history of fracture and fracture risk: a meta-analysis to update the FRAX® risk assessment tool | Osteoporosis international | | | 2025 | 17 | 0 |
|
| Ostéoporose : ces malades qu’on ignore malgré des traitements efficaces | Revue médicale suisse | | | 2025 | 30 | 0 |
|
| Efficacité clinique des traitements de l’ostéoporose | Revue médicale suisse | | | 2025 | 40 | 0 |
|
| Prise en charge de la fragilité osseuse du patient diabétique | Revue médicale suisse | | | 2025 | 39 | 0 |
|
| Alternated activation with relaxation of periosteum stimulates bone modeling and remodeling | Scientific reports | | | 2024 | 57 | 30 |
|
| Sclerostin blockade inhibits bone resorption through PDGF receptor signaling in osteoblast lineage cells | JCI insight | | | 2024 | 124 | 170 |
|
| The challenge of hypophosphatasia diagnosis in adults : results from the HPP International Working Group Literature Surveillance | Osteoporosis international | | | 2024 | 69 | 1 |
|
| Effects of Dalcroze eurhythmics exercise versus multicomponent exercise on physical and cognitive function, and falls in older adults : the EPHYCOS randomized controlled trial | Advanced biology | | | 2024 | 103 | 464 |
|
| Romosozumab followed by denosumab versus denosumab only : a post hoc analysis of FRAME and FRAME extension | Journal of bone and mineral research | | | 2024 | 76 | 1,270 |
|
| Reduced sclerostin expression in human atherosclerotic plaques links to ischemic stroke | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | | | 2024 | 89 | 114 |
|
| Fracture risk based on high-resolution peripheral quantitative computed tomography measures does not vary with age in older adults-the bone microarchitecture international consortium prospective cohort study | Journal of bone and mineral research | | | 2024 | 63 | 0 |
|
| Validation of a fall rate prediction model for community-dwelling older adults : a combined analysis of three cohorts with 1850 participants | BMC geriatrics | | | 2024 | 44 | 246 |
|
| Maladies osseuses : ce qui a changé en 2023 | Revue médicale suisse | | | 2024 | 140 | 125 |
|
| Short-term risk of fracture is increased by deficits in cortical and trabecular bone microarchitecture independent of DXA BMD and FRAX : bone microarchitecture international consortium (BoMIC) prospective cohorts | Journal of bone and mineral research | | | 2024 | 185 | 360 |
|
| Hypophosphatasia diagnosis : current state of the art and proposed diagnostic criteria for children and adults | Osteoporosis international | | | 2024 | 71 | 344 |
|
| 3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate | Journal of bone and mineral research | | | 2024 | 125 | 246 |
|
| Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents : results from the HPP International Working Group | Osteoporosis international | | | 2024 | 46 | 68 |
|
| A meta-analysis of previous falls and subsequent fracture risk in cohort studies | Osteoporosis international | | | 2024 | 92 | 0 |
|
| Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD) : Insight into Clinical Challenges in the Treatment of Type 2 Diabetes | Journal of clinical medicine | | | 2023 | 81 | 261 |
|
| NADPH oxidase 4 deficiency attenuates experimental osteoarthritis in mice | RMD open | | | 2023 | 246 | 133 |
|
| Nouveaux critères de remboursement du dosage de la vitamine D : et nos patients migrants ? | Revue médicale suisse | | | 2023 | 102 | 264 |
|
| High frequency of heterozygous rare variants of the SLC34A1 and SLC9A3R1 genes in patients with atypical femur fracture | European journal of endocrinology | | | 2023 | 237 | 350 |
|
| 2D-3D reconstruction of the proximal femur from DXA scans: Evaluation of the 3D-Shaper software | Frontiers in bioengineering and biotechnology | | | 2023 | 118 | 66 |
|
| Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials | BMJ | | | 2023 | 97 | 36 |
|
| Unusual phosphaturic mesenchymal tumor mimicking osteoid osteoma | Radiology case reports | | | 2023 | 158 | 212 |
|
| Biochemical Markers of Bone Fragility in Patients With Diabetes | The Journal of clinical endocrinology and metabolism | | | 2023 | 100 | 0 |
|
| A Fracture Risk Assessment Tool for High Resolution Peripheral Quantitative Computed Tomography | Journal of bone and mineral research | | | 2023 | 139 | 124 |
|
| The effects of time‐restricted eating and weight loss on bone metabolism and health: a 6‐month randomized controlled trial | Obesity | | | 2023 | 269 | 113 |
|
| Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on bone | Nature reviews. Rheumatology | | | 2023 | 77 | 0 |
|
| Functional brain changes in sarcopenia: evidence for differential central neural mechanisms in dynapenic older women | Aging Clinical and Experimental Research | | | 2023 | 167 | 76 |
|
| Previous fracture and subsequent fracture risk : a meta-analysis to update FRAX | Osteoporosis international | | | 2023 | 93 | 418 |
|
| Development of a personalized fall rate prediction model in community-dwelling older adults: a negative binomial regression modelling approach | BMC geriatrics | | | 2023 | 99 | 265 |
|
| Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism | Nutrients | | | 2022 | 184 | 208 |
|
| Romosozumab efficacy and safety in European patients enrolled in the FRAME trial | Osteoporosis international | | | 2022 | 227 | 185 |
|
| Associations of Calcium Intake and Calcium from Various Sources with Blood Lipids in a Population of Older Women and Men with High Calcium Intake | Nutrients | | | 2022 | 168 | 460 |
|
| Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan | Osteoporosis international | | | 2022 | 258 | 0 |
|
| Fracture risk following an atypical femoral fracture | Journal of bone and mineral research | | | 2022 | 275 | 396 |
|
| Regeneration of Craniofacial Bone Induced by Periosteal Pumping | Tissue engineering. Part C Methods | | | 2022 | 269 | 2 |
|
| Bone Microarchitecture Phenotypes Identified in Older Adults Are Associated With Different Levels of Osteoporotic Fracture Risk | Journal of bone and mineral research | | | 2022 | 361 | 628 |
|
| Pumping the Periosteum : A Feasibility Study | Annals of plastic surgery | | | 2022 | 36 | 0 |
|
| Prevalence of low serum alkaline phosphatase and hypophosphatasia in adult patients with atypical femur fractures | Calcified tissue international | | | 2022 | 393 | 684 |
|
| Pathophysiology of vascular calcification and bone loss: linked disorders of ageing? | Nutrients | | | 2021 | 251 | 293 |
|
| Primary mouse osteoblast and osteoclast culturing and analysis | STAR protocols | | | 2021 | 428 | 713 |
|
| Overweight-obesity is associated with decreased vitamin K2 levels in hemodialysis patients | Clinical chemistry and laboratory medicine | | | 2021 | 313 | 289 |
|
| A Novel HR-pQCT Image Registration Approach Reveals Sex-Specific Changes in Cortical Bone Retraction With Aging | Journal of Bone and Mineral Research | | | 2021 | 208 | 0 |
|
| Reference microarchitectural values measured by HR-pQCT in a Franco-Swiss cohort of young adult women | Osteoporosis international | | | 2021 | 155 | 0 |
|
| Covid 19 - vitamine D - traitement de l'ostéoporose | Revue médicale suisse | | | 2021 | 221 | 200 |
|
| Bone fragility in patients affected by congenital diseases non skeletal in origin | Orphanet Journal of Rare Diseases | | | 2021 | 210 | 402 |
|
| Développement et évaluation des filières de l'ostéoporose en Suisse | Revue médicale suisse | | | 2021 | 309 | 586 |
|
| European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D | Nephrology Dialysis Transplantation | | | 2021 | 255 | 4 |
|
| Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review | Advances in therapy | | | 2021 | 189 | 2,166 |
|
| Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services | Osteoporosis international | | | 2021 | 278 | 364 |
|
| Ostéoporose - Nouvelle molécule, nouvelles directives | Revue médicale suisse | | | 2021 | 132 | 90 |
|
| RANKL‐Induced Increase in Cathepsin K Levels Restricts Cortical Expansion in a Periostin‐Dependent Fashion: A Potential New Mechanism of Bone Fragility | Journal of Bone and Mineral Research | | | 2021 | 286 | 1 |
|
| Lack of Adiponectin Drives Hyperosteoclastogenesis in Lipoatrophic Mice | Frontiers in Cell and Developmental Biology | | | 2021 | 226 | 127 |
|
| Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals | JBMR plus | | | 2021 | 243 | 330 |
|
| Metformin: is it the well wisher of bone beyond glycemic control in diabetes mellitus? | Calcified tissue international | | | 2021 | 288 | 0 |
|
| Oral calcitriol use, vertebral fractures, and vitamin K in hemodialysis patients: a cross‐sectional study | Journal of bone and mineral research | | | 2021 | 207 | 0 |
|
| The vessels-bone axis: iliac artery calcifications, vertebral fractures and vitamin K from VIKI study | Nutrients | | | 2021 | 189 | 255 |
|
| Short or long-term osteoporosis therapy with denosumab ? | Journal of clinical endocrinology & metabolism | | | 2021 | 158 | 187 |
|
| Mechanically Driven Counter‐Regulation of Cortical Bone Formation in Response to Sclerostin‐Neutralizing Antibodies | Journal of Bone and Mineral Research | | | 2021 | 252 | 0 |
|
| Reliability and validity of an adapted hip abductor strength measure as a potential new fall risk assessment for older persons: a study protocol | BMC Geriatrics | | | 2021 | 266 | 257 |
|
| Higher serum levels of a cathepsin K–generated periostin fragment are associated with fractures in postmenopausal women with primary hyperparathyroidism: a pilot study | Osteoporosis international | | | 2021 | 130 | 0 |
|
| Romosozumab : un nouveau traitement de l'ostéoporose sévère | Revue médicale suisse | | | 2021 | 1,185 | 1,664 |
|
| Associations between age-related changes in bone microstructure and strength and dietary acid load in a cohort of community-dwelling, healthy men and postmenopausal women | The American Journal of Clinical Nutrition | | | 2020 | 280 | 5 |
|
| A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement | Osteoporosis International | | | 2020 | 315 | 242 |
|
| 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO) | Swiss Medical Weekly | | | 2020 | 499 | 1,147 |
|
| Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF | The Journal of clinical endocrinology and metabolism | | | 2020 | 174 | 504 |
|
| Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk | Osteoporosis International | | | 2020 | 243 | 0 |
|
| Sevelamer use, vitamin K levels, vascular calcifications and vertebral fractures in hemodialysis patients: results from the VIKI study | Journal of Bone and Mineral Research | | | 2020 | 219 | 628 |
|
| Ostéoporose | Revue médicale suisse | | | 2020 | 138 | 352 |
|
| Hand grip strength and early mortality after hip fracture | Archives of Osteoporosis | | | 2020 | 223 | 0 |
|
| Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension | Bone | | | 2020 | 367 | 2 |
|
| Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed | Bone | | | 2020 | 308 | 2 |
|
| Zoledronate Following Denosumab Discontinuation: Partial Reassurance but No Confidence | Journal of Bone and Mineral Research | | | 2020 | 279 | 5 |
|
| The role of hip abductor strength in identifying older persons at risk of falls: a diagnostic accuracy study | Clinical Interventions in Aging | | | 2020 | 445 | 395 |
|
| T-score as an indicator of fracture risk during treatment with romosozumab or alendronate in the ARCH trial | Journal of Bone and Mineral Research | | | 2020 | 312 | 160 |
|
| Vitamin K and Osteoporosis | Nutrients | | | 2020 | 243 | 634 |
|
| Fracture risk following intermission of osteoporosis therapy | Osteoporosis International | | | 2019 | 340 | 1 |
|
| Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment | Journal of Clinical Endocrinology and Metabolism | | | 2019 | 354 | 1 |
|
| RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass | Journal of Clinical Investigation | | | 2019 | 450 | 477 |
|
| Associations between radius low-frequency axial ultrasound velocity and bone fragility in elderly men and women | Osteoporosis International | | | 2019 | 322 | 1 |
|
| Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study | The Lancet Diabetes & Endocrinology | | | 2019 | 407 | 0 |
|
| Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis | Osteoporosis International | | | 2019 | 365 | 1 |
|
| Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis | Advances in Therapy | | | 2019 | 305 | 203 |
|
| Relationship Between Bone Mineral Density T‐Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment | Journal of Bone and Mineral Research | | | 2019 | 444 | 447 |
|
| Higher rates of osteoporosis treatment initiation and persistence in patients with newly diagnosed vertebral fracture when introduced in inpatients than later in outpatients | Osteoporosis International | | | 2019 | 342 | 1 |
|
| Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific Region | Journal of Clinical Densitometry | | | 2019 | 317 | 352 |
|
| Diabetes and fracture risk | Primer on the metabolic bone diseases and disorders of mineral metabolism | | | 2019 | 316 | 3 |
|
| Hip muscle and hand-grip strength to differentiate between older fallers and non-fallers: a cross-sectional validity study | Clinical Interventions in Aging | | | 2018 | 578 | 370 |
|
| Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension | Journal of Bone and Mineral Research | | | 2018 | 466 | 1 |
|
| Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture Outcome | Journal of Bone and Mineral Research | | | 2018 | 441 | 0 |
|
| Evaluation of Radius Microstructure and Areal Bone Mineral Density Improves Fracture Prediction in Postmenopausal Women | Journal of Bone and Mineral Research | | | 2018 | 626 | 0 |
|
| Fermented dairy products consumption is associated with attenuated cortical bone loss independently of total calcium, protein, and energy intakes in healthy postmenopausal women | Osteoporosis International | | | 2018 | 472 | 6 |
|
| β-Klotho deficiency shifts the gut-liver bile acid axis and induces hepatic alterations in mice | American Journal of Physiology. Endocrinology and Metabolism | | | 2018 | 436 | 4 |
|
| Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructure | Osteoporosis International | | | 2018 | 608 | 1 |
|
| FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab | Journal of Bone and Mineral Research | | | 2018 | 447 | 0 |
|
| Osteoporosis: Romosozumab to rebuild the foundations of bone strength | Nature Reviews Rheumatology | | | 2018 | 469 | 0 |
|
| Ostéoporose | Revue médicale suisse | | | 2018 | 349 | 2 |
|
| Phosphate wasting disorders in adults | Osteoporosis International | | | 2018 | 435 | 1 |
|
| Recipient rs1045642 Polymorphism Is Associated With Office Blood Pressure at 1-Year Post Kidney Transplantation: A Single Center Pharmacogenetic Cohort Pilot Study | Frontiers in Pharmacology | | | 2018 | 561 | 302 |
|
| Selective inhibition of Src family kinases by SU6656 increases bone mass by uncoupling bone formation from resorption in mice | Bone | | | 2018 | 471 | 3 |
|
| Functional Performances on Admission Predict In-Hospital Falls, Injurious Falls, and Fractures in Older Patients: A Prospective Study | Journal of Bone and Mineral Research | | | 2018 | 544 | 3 |
|
| Ostéoporose chez l'insuffisant rénal : quelle évaluation et quel traitement? Place de la biopsie osseuse | Revue médicale suisse | | | 2018 | 414 | 1 |
|
| The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis | Calcified Tissue International | | | 2018 | 404 | 0 |
|
| Prevention of fractures in patients with osteoporosis | The Lancet | | | 2018 | 476 | 1 |
|
| Intra-rater reliability of hip abductor isometric strength testing in a standing position in older fallers and non-fallers | European Review of Aging and Physical Activity | | | 2018 | 474 | 405 |
|
| Ostéoporose | Revue médicale suisse | | | 2018 | 454 | 172 |
|
| Diagnosis and management of bone fragility in diabetes: an emerging challenge | Osteoporosis International | | | 2018 | 440 | 343 |
|
| Les métamorphoses du traitement de l'ostéoporose | Revue médicale suisse | | | 2017 | 396 | 62 |
|
| Evaluation of hip abductor and adductor strength in the elderly: a reliability study | European review on aging and physical activity | | | 2017 | 517 | 353 |
|
| Serum Levels of a Cathepsin-K Generated Periostin Fragment Predict Incident Low-Trauma Fractures in Postmenopausal Women Independently of BMD and FRAX | Journal of Bone and Mineral Research | | | 2017 | 533 | 0 |
|
| Development of a New Immunoassay for Human Cathepsin K-Generated Periostin Fragments as a Serum Biomarker for Cortical Bone | Calcified Tissue International | | | 2017 | 535 | 1 |
|
| Cathepsin K Controls Cortical Bone Formation by Degrading Periostin | Journal of Bone and Mineral Research | | | 2017 | 484 | 1 |
|
| IOF Compendium of Osteoporosis | | | | 2017 | 1,409 | 442 |
|
| Peripheral skeleton bone strength is positively correlated with total and dairy protein intakes in healthy postmenopausal women | The American journal of clinical nutrition | | | 2017 | 695 | 3 |
|
| Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study | BMC musculoskeletal disorders | | | 2017 | 495 | 294 |
|
| Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonates | Osteoporosis International | | | 2017 | 553 | 2 |
|
| Mechanisms of diabetes mellitus-induced bone fragility | Nature reviews. Endocrinology | | | 2017 | 569 | 0 |
|
| Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO | Swiss Medical Weekly | | | 2017 | 517 | 258 |
|
| Prepubertal Impact of Protein Intake and Physical Activity on Weight-Bearing Peak Bone Mass and Strength in Males | The Journal of clinical endocrinology and metabolism | | | 2017 | 561 | 0 |
|
| Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC) | Inflammatory Bowel Diseases | | | 2017 | 586 | 1 |
|
| Traitement médicamenteux de l'ostéoporose: durée et procédure après la fin du traitement | Swiss Medical Forum | | | 2017 | 394 | 1 |
|
| Diabetes and Bone | Calcified tissue international | | | 2017 | 468 | 1 |
|
| Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting | Osteoporosis International | | | 2017 | 457 | 0 |
|
| hypophosphatasie de l'adulte | Revue médicale suisse | | | 2017 | 529 | 6 |
|
| Jusqu'où et jusqu'à quand traiter l'ostéoporose? | Revue médicale suisse | | | 2017 | 439 | 147 |
|
| Fracture Prospectively Recorded From Prepuberty to Young Adulthood: Are They Markers of Peak Bone Mass and Strength in Males? | Journal of Bone and Mineral Research | | | 2017 | 517 | 0 |
|
| Within and across-sex inheritance of bone microarchitecture | The Journal of clinical endocrinology and metabolism | | | 2017 | 1,524 | 10 |
|
| Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis | Therapeutic advances in musculoskeletal disease | | | 2016 | 544 | 0 |
|
| Le traitement séquentiel présente des avantages | Leading Opinions. Médecine Interne | | | 2016 | 413 | 1 |
|
| Osteoporosis drug effects on cortical and trabecular bone microstructure: a review of HR-pQCT analyses | BoneKEy Reports | | | 2016 | 444 | 273 |
|
| Traitement de l'ostéoporose : quel médicament et pour qui? | La gazette médicale - info@gériatrie | | | 2016 | 531 | 1,396 |
|
| Influence of Fatigue Loading and Bone Turnover on Bone Strength and Pattern of Experimental Fractures of the Tibia in Mice | Calcified tissue international | | | 2016 | 594 | 3 |
|
| Low Lean Mass Predicts Incident Fractures Independently From FRAX: a Prospective Cohort Study of Recent Retirees | Journal of bone and mineral research | | | 2016 | 613 | 7 |
|
| The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club | Osteoporosis international | | | 2016 | 495 | 0 |
|
| Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture | Archives of osteoporosis | | | 2016 | 553 | 347 |
|
| Periostin action in bone | Molecular and cellular endocrinology | | | 2016 | 435 | 0 |
|
| Mechanisms in Endrocrinology: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus | European journal of endocrinology | | | 2016 | 480 | 1 |
|
| Occupation-dependent loading increases bone strength in men | Osteoporosis international | | | 2016 | 677 | 3 |
|
| Romosozumab Treatment in Postmenopausal Women with Osteoporosis | The New England journal of medicine | | | 2016 | 1,077 | 1,835 |
|
| Santé osseuse des retraités genevois | Revue médicale suisse | | | 2015 | 527 | 2 |
|
| Gene–Diet Interactions on Bone | Nutrition and Bone Health | | | 2015 | 660 | 1 |
|
| Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years | Osteoporosis international | | | 2015 | 540 | 0 |
|
| Periostin expression contributes to cortical bone loss during unloading | Bone | | | 2015 | 561 | 1 |
|
| Calcinose cutanée associée aux connectivites | Revue médicale suisse | | | 2015 | 1,152 | 3 |
|
| Taxonomy of rare genetic metabolic bone disorders | Osteoporosis international | | | 2015 | 570 | 0 |
|
| Additive Genetic Effects on Circulating Periostin Contribute to the Heritability of Bone Microstructure | The Journal of clinical endocrinology and metabolism | | | 2015 | 620 | 0 |
|
| Sauvons l'ostéoporose | Revue médicale suisse | | | 2015 | 472 | 0 |
|
| Prior ankle fractures in postmenopausal women are associated with low areal bone mineral density and bone microstructure alterations | Osteoporosis international | | | 2015 | 613 | 1 |
|
| Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial | The Lancet. Diabetes & endocrinology | | | 2015 | 582 | 0 |
|
| Osteocytic targets in the treatment of osteoporosis | Osteoporosis international | | | 2014 | 494 | 0 |
|
| The role of teriparatide in sequential and combination therapy of osteoporosis | Schweizerische medizinische Wochenschrift | | | 2014 | 700 | 1 |
|
| Association of LRP5 genotypes with osteoporosis in Tunisian post-menopausal women | BMC musculoskeletal disorders | | | 2014 | 749 | 196 |
|
| Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifene | Current medical research and opinion | | | 2014 | 532 | 0 |
|
| Goal-directed treatment of osteoporosis in Europe | Osteoporosis international | | | 2014 | 547 | 1 |
|
| Future directions for new medical entities in osteoporosis | Baillière's best practice & research. Clinical endocrinology & metabolism | | | 2014 | 490 | 0 |
|
| Fractures ostéoporotiques: pas seulement chez les femmes | Revue médicale suisse | | | 2014 | 505 | 0 |
|
| Novel Genetic Models of Osteoporosis by Overexpression of Human RANKL in Transgenic Mice | Journal of bone and mineral research | | | 2014 | 625 | 0 |
|
| Tracking of Environmental Determinants of Bone Structure and Strength Development in Healthy Boys: An Eight-Year Follow Up Study on the Positive Interaction Between Physical Activity and Protein Intake From Prepuberty to Mid-Late Adolescence | Journal of bone and mineral research | | | 2014 | 679 | 1 |
|
| Impaired Musculoskeletal Response to Age and Exercise in PPARβ −/− Diabetic Mice | Endocrinology | | | 2014 | 547 | 479 |
|
| Fracture history of healthy premenopausal women is associated with a reduction of cortical microstructural components at the distal radius | Bone | | | 2013 | 579 | 0 |
|
| Zoledronate Effects on Systemic and Jaw Osteopenias in Ovariectomized Periostin-Deficient Mice | PloS one | | | 2013 | 678 | 410 |
|
| Effect of a multifactorial fall-and-fracture risk assessment and management program on gait and balance performances and disability in hospitalized older adults: a controlled study | Osteoporosis international | | | 2013 | 640 | 625 |
|
| Effects of an Interleukin-15 Antagonist on Systemic and Skeletal Alterations in Mice with DSS-Induced Colitis | The American journal of pathology | | | 2013 | 566 | 0 |
|
| Association of Circulating Sclerostin With Bone Mineral Mass, Microstructure, and Turnover Biochemical Markers in Healthy Elderly Men and Women | The Journal of clinical endocrinology and metabolism | | | 2013 | 742 | 0 |
|
| Eliminating the need for fasting with oral administration of bisphosphonates | Therapeutics and clinical risk management | | | 2013 | 639 | 515 |
|
| Diabète et ostéoporose | Revue médicale suisse | | | 2013 | 575 | 0 |
|
| Periostin Deficiency Increases Bone Damage and Impairs Injury Response to Fatigue Loading in Adult Mice | PloS one | | | 2013 | 622 | 343 |
|
| Peak bone mass and its regulation | Pediatric Bone, Second Edition | | | 2012 | 539 | 2 |
|
| A botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axis | The Journal of clinical investigation | | | 2012 | 797 | 0 |
|
| Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long-term continuation on bone turnover and fracture risk-a perspective | Journal of bone and mineral research | | | 2012 | 594 | 0 |
|
| Osteoporosis in young adults: pathophysiology, diagnosis, and management | Osteoporosis international | | | 2012 | 717 | 1,984 |
|
| Antidepressant medications and osteoporosis | Bone | | | 2012 | 606 | 0 |
|
| Deletion of β-adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation | Journal of bone and mineral research | | | 2012 | 572 | 0 |
|
| Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association? | Osteoporosis international | | | 2012 | 630 | 0 |
|
| Physical activity increases bone mineral density in children with type 1 diabetes | Medicine and science in sports and exercise | | | 2012 | 681 | 1 |
|
| Behandlung der Osteoporose mit Denosumab | Therapeutische Umschau | | | 2012 | 568 | 0 |
|
| Fractures in Healthy Females Followed from Childhood to Early Adulthood Are Associated with Later Menarcheal Age and with Impaired Bone Microstructure at Peak Bone Mass | The Journal of clinical endocrinology and metabolism | | | 2012 | 646 | 0 |
|
| Improvement of bone strength with teriparatide: hip as well as spine? | IBMS boneKEy | | | 2012 | 430 | 0 |
|
| Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin | Proceedings of the National Academy of Sciences of the United States of America | | | 2012 | 694 | 0 |
|
| Deficiency in the NADPH oxidase 4 predisposes towards diet-induced obesity | International journal of obesity | | | 2012 | 777 | 5 |
|
| Effect of music-based multitask training on gait, balance, and fall risk in elderly people: a randomized controlled trial | Archives of internal medicine | | | 2011 | 736 | 2 |
|
| Do RANKL inhibitors (denosumab) affect inflammation and immunity? | Osteoporosis international | | | 2011 | 707 | 1,395 |
|
| Fractures during childhood and adolescence in healthy boys: relation with bone mass, microstructure, and strength | The Journal of clinical endocrinology and metabolism | | | 2011 | 687 | 442 |
|
| Prévention des chutes par une méthode d'exercice en musique (rythmique Jaques-Dalcroze) | Revue médicale suisse | | | 2011 | 708 | 2 |
|
| Longitudinal change in hip fracture incidence after starting risedronate or raloxifene: an observational study | Journal of bone and mineral metabolism | | | 2011 | 584 | 267 |
|
| Early post-transplantation hypophosphatemia is associated with elevated FGF-23 levels | European journal of endocrinology | | | 2011 | 609 | 835 |
|
| Bisphosphonates in periodontitis: Friend or foe? | IBMS boneKEy | | | 2011 | 733 | 0 |
|
| Denosumab and bisphosphonates: Different mechanisms of action and effects | Bone | | | 2011 | 700 | 0 |
|
| Protéines et croissance osseuse | Archives de pédiatrie | | | 2011 | 581 | 1 |
|
| Pubertal timing and body mass index gain from birth to maturity in relation with femoral neck BMD and distal tibia microstructure in healthy female subjects | Osteoporosis international | | | 2011 | 682 | 345 |
|
| Effects of long-term supplementation with omega-3 fatty acids on longitudinal changes in bone mass and microstructure in mice | The Journal of nutritional biochemistry | | | 2011 | 576 | 1 |
|
| Traitement de l'ostéoporose par les agents biologiques | Je veux en savoir plus | | | 2011 | 483 | 0 |
|
| Mechanisms inducing low bone density in duchenne muscular dystrophy in mice and humans | Journal of bone and mineral research | | | 2011 | 594 | 0 |
|
| Decreased bone turnover in children and adolescents with well controlled type 1 diabetes | Journal of pediatric endocrinology & metabolism | | | 2010 | 619 | 2 |
|
| Comparing and contrasting the effects of strontium ranelate and other osteoporosis drugs on microarchitecture | Osteoporosis international | | | 2010 | 625 | 447 |
|
| Ostéoporose: du diagnostic ostéodensitométrique à l'évaluation du risque absolu de fracture | Journal für Mineralstoffwechsel | | | 2010 | 617 | 3 |
|
| Pathophysiology of postmenopausal osteoporosis | Atlas of Postmenopausal Osteoporosis. Third Edition | | | 2010 | 545 | 0 |
|
| Exercise and the skeleton: How it works and what it really does | IBMS boneKEy | | | 2010 | 993 | 2,308 |
|
| Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL | The Journal of biological chemistry | | | 2010 | 787 | 0 |
|
| Development of a new ELISA for serum periostin: evaluation of growth-related changes and bisphosphonate treatment in mice | Calcified tissue international | | | 2010 | 663 | 0 |
|
| Age de la ménarche et risque d'ostéoporose au cours de la vie adulte | Mises au point cliniques d'endocrinologie, nutrition et métabolisme | | | 2010 | 530 | 2 |
|
| An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traits | PLOS genetics | | | 2010 | 1,086 | 415 |
|
| Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient mice | Arthritis and rheumatism | | | 2010 | 546 | 0 |
|
| β-Arrestin-biased parathyroid hormone ligands: A new approach to the development of agents that stimulate bone formation | Science translational medicine | | | 2009 | 559 | 0 |
|
| The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activity | The Journal of biological chemistry | | | 2009 | 637 | 1 |
|
| Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight | PloS one | | | 2009 | 710 | 518 |
|
| Beta-arrestin2 regulates parathyroid hormone effects on a p38 MAPK and NFkappaB gene expression network in osteoblasts | Bone | | | 2009 | 665 | 669 |
|
| Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases | International journal of clinical practice | | | 2009 | 582 | 0 |
|
| Mice lacking beta-adrenergic receptors have increased bone mass but are not protected from deleterious skeletal effects of ovariectomy | Endocrinology | | | 2009 | 630 | 0 |
|
| The influence of pubertal timing on bone mass acquisition: a predetermined trajectory detectable five years before menarche | The Journal of clinical endocrinology and metabolism | | | 2009 | 601 | 1 |
|
| Deleterious effect of late menarche on distal tibia microstructure in healthy 20-year-old and premenopausal middle-aged women | Journal of bone and mineral research | | | 2009 | 626 | 0 |
|
| Continuous broad protection against osteoporotic fractures with strontium ranelate | Rheumatology | | | 2009 | 629 | 1 |
|
| Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice | Journal of bone and mineral research | | | 2009 | 588 | 0 |
|
| Differentiation of osteoporotic and neoplastic vertebral fractures by chemical shift {in-phase and out-of phase} MR imaging | European journal of radiology | | | 2009 | 610 | 0 |
|
| Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis | Journal of Musculoskeletal and Neuronal Interactions | | | 2008 | 566 | 0 |
|
| PPARG by dietary fat interaction influences bone mass in mice and humans | Journal of bone and mineral research | | | 2008 | 596 | 0 |
|
| High-protein intake enhances the positive impact of physical activity on BMC in prepubertal boys | Journal of bone and mineral research | | | 2008 | 613 | 0 |
|
| Secondary prevention of osteoporotic fractures: why not apply the evidence? | Schweizerische medizinische Wochenschrift | | | 2008 | 537 | 0 |
|
| Influence of age at menarche on forearm bone microstructure in healthy young women | The Journal of clinical endocrinology and metabolism | | | 2008 | 710 | 0 |
|
| Caloric restriction decreases cortical bone mass but spares trabecular bone in the mouse skeleton: implications for the regulation of bone mass by body weight | Journal of bone and mineral research | | | 2008 | 597 | 0 |
|
| Genomewide Association Studies in Osteoporosis: Have We Reached the Bottom of the Ocean or the Tip of the Iceberg? | IBMS boneKEy | | | 2008 | 550 | 0 |
|
| Leptin and the sympathetic connection of fat to bone | Osteoporosis international | | | 2008 | 600 | 0 |
|
| Contribution of gender-specific genetic factors to osteoporosis risk | Annals of human genetics | | | 2008 | 537 | 0 |
|
| Site specificity of fracture prediction in children | Journal of bone and mineral research | | | 2008 | 499 | 0 |
|
| Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis | JAMA | | | 2008 | 609 | 0 |
|
| Human genetics of osteoporosis | Baillière's best practice & research. Clinical endocrinology & metabolism | | | 2008 | 647 | 2 |
|
| Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass | Current opinion in lipidology | | | 2005 | 586 | 0 |
|
| LRP5 gene polymorphisms and idiopathic osteoporosis in men | Bone | | | 2005 | 602 | 0 |
|
| beta-Arrestin2, interacting with phosphodiesterase 4, regulates synaptic release probability and presynaptic inhibition by opioids | Proceedings of the National Academy of Sciences of the United States of America | | | 2005 | 572 | 0 |
|
| Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites | American journal of human genetics | | | 2004 | 584 | 0 |
|
| Parathyroid hormone-related protein increases cAMP production in mammary epithelial cells | The American journal of physiology | | | 1993 | 570 | 0 |
|
